Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physical Activity and PK-guided EHL FVIII in Severe Hemophilia A
NCT05728528Phase 4Completed
- Sponsor
- Chulalongkorn University
- Start
- Jul 2022
- Primary completion
- Dec 2022
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of rurioctocog alfa pegol in hemophilia A, sponsored by Chulalongkorn University. Started Jul 2022; status: completed.
02
Drugs
rurioctocog alfa pegol
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT05728528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05728528.